Switch to:
ChemoCentryx Inc (NAS:CCXI)
EV/EBITDA
-2.79 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, ChemoCentryx Inc's enterprise value is $140.88 Mil. ChemoCentryx Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $-50.58 Mil. Therefore, ChemoCentryx Inc's EV/EBITDA ratio for today is -2.79.

CCXI' s EV/EBITDA Range Over the Past 10 Years
Min: -86   Max: -0.1
Current: -2.78

-86
-0.1

During the past 7 years, the highest EV/EBITDA Ratio of ChemoCentryx Inc was -0.10. The lowest was -86.00. And the median was -5.15.

CCXI's EV/EBITDA is ranked lower than
99.99% of the 319 Companies
in the Global Biotechnology industry.

( Industry Median: 17.75 vs. CCXI: -2.78 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, ChemoCentryx Inc's stock price is $4.63. ChemoCentryx Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $-1.14. Therefore, ChemoCentryx Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

ChemoCentryx Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=140.881/-50.582
=-2.79

ChemoCentryx Inc's current Enterprise Value is $140.88 Mil.
ChemoCentryx Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was -11.952 (Jun. 2015 ) + -11.531 (Sep. 2015 ) + -11.856 (Dec. 2015 ) + -15.243 (Mar. 2016 ) = $-50.58 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

ChemoCentryx Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=4.63/-1.14
=

ChemoCentryx Inc's share price for today is $4.63.
ChemoCentryx Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was -0.28 (Jun. 2015 ) + -0.26 (Sep. 2015 ) + -0.26 (Dec. 2015 ) + -0.34 (Mar. 2016 ) = $-1.14.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

ChemoCentryx Inc Annual Data

Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda 0.000.000.000.000.000.00-7.68-3.03-4.82-6.06

ChemoCentryx Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda -3.03-3.90-3.65-2.51-4.82-5.41-6.24-4.07-6.06-0.91
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK